Since 2022, he has also served as Chief Scientific Officer at DEM BioPharma, driving the development ... Find out more at www.egle-tx.com.

Before joining Egle, he founded and led Ovie Therapeutics, a company focused on an innovative treatment for brain cancer. Since 2022, he has also served as Chief Scientific Officer at DEM BioPharma, ...